Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 0 | 0 | 0 | 185 | 118 |
| Gross Profit | N/A | N/A | N/A | 185 | 118 |
| Operating Expenses | 2,479 | 3,395 | 1,396 | 2,537 | 2,559 |
| Operating Income | -2,479 | -3,395 | -1,396 | -2,352 | -2,441 |
| Interest Expense | 247 | 253 | 253 | 252 | 349 |
| Other Income | 6 | 61 | -79 | 765 | 1,703 |
| Pre-tax Income | -2,720 | -3,587 | -1,728 | -1,839 | -1,087 |
| Net Income Continuous | -2,720 | -3,587 | -1,728 | -1,839 | -1,087 |
| Net Income | $-2,720 | $-3,587 | $-1,728 | $-1,839 | $-1,087 |
| EPS Basic Total Ops | -123.69 | -277.36 | -146.18 | -168.67 | -104.95 |
| EPS Basic Continuous Ops | -123.31 | -275.39 | -147.13 | -170.07 | -104.98 |
| EPS Diluted Total Ops | -123.69 | -277.36 | -146.18 | -168.67 | -104.95 |
| EPS Diluted Continuous Ops | -123.31 | -275.39 | -147.13 | -170.07 | -104.98 |
| EBITDA(a) | $-2,240 | $-3,146 | $-1,158 | $-2,105 | $-2,225 |